Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

465.89
-2.6900-0.57%
Post-market: 465.890.1250+0.03%19:31 EDT
Volume:630.78K
Turnover:295.36M
Market Cap:61.07B
PE:-189.09
High:475.69
Open:468.29
Low:465.48
Close:468.58
52wk High:484.21
52wk Low:205.87
Shares:131.08M
Float Shares:126.15M
Volume Ratio:0.41
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4638
EPS(LYR):-2.1790
ROE:-257.82%
ROA:-2.63%
PB:243.70
PE(LYR):-213.80

Loading ...

Mar 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Correspondence

Form CORRESP - Correspondence